Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06846411 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The EMPA-FIT Study

Study acronym: EMPA-FIT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 26, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This multicenter, open-label, prospective study randomized 46 drug-naïve adults with T2D (HbA1c 6.5%-10.0%) to receive empagliflozin (10 mg/day) or metformin (1,000 mg/day) for 12 weeks.
Trial Details
NCT Number NCT06846411
Lead Sponsor Seoul National University Bundang Hospital
Conditions
(from sponsor)		 Diabetes, Diabetes Mellitus, Type II
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov